The World Drug Safety Congress Americas will bring together 1000+ top leaders and stakeholders in biopharma to discuss the key challenges they are facing in pharmacovigilance and device safety. Explore strategies in data management & signal detection, showcase how AI & machine learning have improved PV processes, discuss the challenges creating a PV strategy for advanced therapies, and collaborate on medical device safety strategies.
Dr. Aarekh Shrestha, Senior Manager of Drug Safety, will present “Medical Device Vigilance from an EU MDR Perspective” on October 5th at 11:20 AM.
Connect with Veranex delegates:
Elias Sayias, Director of Business Development
Dr. Aarekh Shrestha, Senior Manager of Drug Safety